The Potential of Biotechnology to Improve the Quality of Life of Patients with Renal Failure

This publication has 45 references indexed in Scilit:

• Is Erythropoietin Effective for Impotence in Dialysis Patients?
  Nephron, 1990
• Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease
  Annals of Internal Medicine, 1989
• Measuring quality of life in clinical trials: a taxonomy and review.
  1989
• The Use of Monoclonal Antibodies in Fine Needle Aspiration Biopsy of the Renal Transplant
  American Journal of Kidney Diseases, 1988
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial
  The American Journal of Medicine, 1986
• The Effects of Antihypertensive Therapy on the Quality of Life
  New England Journal of Medicine, 1986
• Measuring disease-specific quality of life in clinical trials.
  1986
• How should we measure function in patients with chronic heart and lung disease?
  Journal of Chronic Diseases, 1985
• Purification of human erythropoietin.
  Journal of Biological Chemistry, 1977